Transgene Completes Safety and Tolerability Assessment of TG4001 in Combination with Avelumab in Phase 1b Part of Trial in HPV-Positive Cancer Patients - Associated Press

Transgene Completes Safety and Tolerability Assessment of TG4001 in Combination with Avelumab in Phase 1b Part of Trial in HPV-Positive Cancer Patients  Associated Press

STRASBOURG, France--(BUSINESS WIRE)--Dec 20, 2018--Regulatory News: Transgene (Paris:TNG), a biotechnology company that designs and develops ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2EFrnw8